| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1241109
Max Phase: Preclinical
Molecular Formula: C13H9ClFNO
Molecular Weight: 249.67
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Oc1ccc(F)cc1/C=N/c1ccccc1Cl
Standard InChI: InChI=1S/C13H9ClFNO/c14-11-3-1-2-4-12(11)16-8-9-7-10(15)5-6-13(9)17/h1-8,17H/b16-8+
Standard InChI Key: AJYCTBQDHHCRDR-LZYBPNLTSA-N
Associated Targets(non-human)
Pseudomonas fluorescens 1630 Activities
Escherichia coli 133304 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Bacillus subtilis 32866 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Staphylococcus aureus 210822 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 249.67 | Molecular Weight (Monoisotopic): 249.0357 | AlogP: 3.94 | #Rotatable Bonds: 2 |
| Polar Surface Area: 32.59 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.57 | CX Basic pKa: 0.11 | CX LogP: 4.29 | CX LogD: 4.26 |
| Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.80 | Np Likeness Score: -1.48 |
References
| 1. Shi L, Fang RQ, Zhu ZW, Yang Y, Cheng K, Zhong WQ, Zhu HL.. (2010) Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents., 45 (9): [PMID:20557983] [10.1016/j.ejmech.2010.05.033] |
Source
Source(1):